Exact Mass: 260.0814

Exact Mass Matches: 260.0814

Found 16 metabolites which its exact mass value is equals to given mass value 260.0814, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

2'-Fluorothymidine

1-[3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H13FN2O5 (260.0808)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors 2'-Fluorothymidine (2'-Fluoro-2'-deoxythymidine), a bioisostere of both thymidine (TdR) and methyluridine, is a putative highly selective substrate for thymidine kinase type 2 (TK2)[1].

   

Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)-

1-[3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H13FN2O5 (260.0808)


   

Fluorothymidine

1-[2-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H13FN2O5 (260.0808)


   

2-[[(4-cyano-1-phenylpyrazol-3-yl)amino]methylidene]propanedinitrile

2-[[(4-cyano-1-phenylpyrazol-3-yl)amino]methylidene]propanedinitrile

C14H8N6 (260.081)


   
   

Clevudine

Clevudine

C10H13FN2O5 (260.0808)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Clevudine (L-FMAU), a nucleoside analog of the unnatural L-configuration, has potent anti-HBV activity with long half-life, low toxicity. Clevudine is a non-competitive inhibitor that is not incorporated into the viral DNA but rather binds to the polymerase. Clevudine is active against cowpox virus respiratory infection in mice[1][2][3].

   

PSI-6206

PSI-6206

C10H13FN2O5 (260.0808)


PSI-6206 (RO 2433) is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase. PSI-6206 low potently inhibits HCV replicon with EC90 of >100 μM.

   

HEPES sodium salt

Sodium 2-(4-(2-hydroxyethyl)piperazin-1-yl)ethanesulfonate

C8H17N2NaO4S (260.0807)


   

D-Arginine methyl ester hydrochloride

D-Arginine methyl ester hydrochloride

C7H18Cl2N4O2 (260.0807)


   

2-Fluoro-5-methylarabinosyluracil

2-Fluoro-5-methylarabinosyluracil

C10H13FN2O5 (260.0808)


   

5-Methyl-2-fluoroarauracil F-18

5-Methyl-2-fluoroarauracil F-18

C10H13FN2O5 (260.0808)


C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate

   

Diethyl 4-Methoxyphenyl Phosphate

Diethyl 4-Methoxyphenyl Phosphate

C11H17O5P (260.0814)


   

Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)-

1-[3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H13FN2O5 (260.0808)


   

1-[2-Fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione

1-[2-Fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione

C10H13FN2O5 (260.0808)


   

5-chloro-4,6-dihydroxy-3-(3-hydroxy-3-methylbut-1-en-1-yl)-6-methylcyclohex-2-en-1-one

5-chloro-4,6-dihydroxy-3-(3-hydroxy-3-methylbut-1-en-1-yl)-6-methylcyclohex-2-en-1-one

C12H17ClO4 (260.0815)


   

(4r,5s,6s)-5-chloro-4,6-dihydroxy-3-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-6-methylcyclohex-2-en-1-one

(4r,5s,6s)-5-chloro-4,6-dihydroxy-3-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-6-methylcyclohex-2-en-1-one

C12H17ClO4 (260.0815)